Detalles de la búsqueda
1.
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
Haematologica
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721749
2.
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Blood
; 138(21): 2031-2041, 2021 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407542
3.
Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell source.
Cytotherapy
; 25(12): 1331-1337, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37737766
4.
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.
Haematologica
; 107(5): 1045-1053, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34382386
5.
Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts.
Ann Hematol
; 101(2): 421-428, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34719735
6.
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
Biol Blood Marrow Transplant
; 26(6): 1137-1143, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32062061
7.
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.
Biol Blood Marrow Transplant
; 26(3): 472-479, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31669399
8.
Role of Physical Therapy before and after Hematopoietic Stem Cell Transplantation: White Paper Report.
Biol Blood Marrow Transplant
; 25(6): e191-e198, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30658224
9.
CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results.
Haematologica
; 102(11): 1936-1946, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28935847
10.
The journey toward personalized cancer therapy.
Adv Anat Pathol
; 21(1): 36-43, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24316909
11.
[Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation].
Rinsho Ketsueki
; 55(6): 607-32, 2014 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-24975331
12.
Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin.
Transplant Cell Ther
; 30(3): 312.e1-312.e7, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38185379
13.
Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients.
Ann Saudi Med
; 44(2): 93-103, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615184
14.
Outcomes and Long-Term Survival of Adolescent and Young Adult Patients Admitted to the Intensive Care Unit Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience of 152 Patients.
Hematol Oncol Stem Cell Ther
; 17(2): 110-119, 2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38560973
15.
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update.
Transplant Cell Ther
; 30(4): 349-385, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38413247
16.
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.
Bone Marrow Transplant
; 2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38413823
17.
Successful restoration of checkpoint inhibitors efficacy after allogeneic hematopoietic cell transplant for classic Hodgkin lymphoma patients.
Semin Oncol
; 50(3-5): 76-85, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37598020
18.
Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia.
Int J Hematol Oncol
; 12(1): IJH42, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36874377
19.
"Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation".
Bone Marrow Transplant
; 58(6): 680-686, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36959370
20.
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL.
Leukemia
; 37(3): 617-626, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36717654